The emerging role of community sentinel surveillance in the understanding of the clinical features and epidemiology of acute Mycoplasma pneumoniae infection

Clinical Microbiology and Infection

Volumn 20, Issue 8, 2014, Pages

  Moore, C ^a   Perry, M ^a   Cottrell, S ^b  

^a UNIVERSITY HOSPITAL OF WALES   (United Kingdom)

^b PUBLIC HEALTH WALES   (United Kingdom)

Author keywords

Community acquired pneumonia; M. pneumoniae NAAT; Molecular diagnostics; Mycoplasma pneumoniae; Sentinel surveillance

Indexed keywords

ANTIBIOTIC AGENT; ANTIBODY; BACTERIAL DNA; IMMUNOGLOBULIN M;

ALGORITHM; ANTIBODY BLOOD LEVEL; ANTIBODY TITER; ANTIGEN ANTIBODY REACTION; ARTICLE; CLINICAL FEATURE; COMMUNITY SENTINEL SURVEILLANCE; CONVALESCENCE; CROSS REACTION; FALSE NEGATIVE RESULT; HOSPITALIZATION; HUMAN; LOWER RESPIRATORY TRACT; MASS SCREENING; MYCOPLASMA PNEUMONIA; NONHUMAN; NUCLEIC ACID AMPLIFICATION; PNEUMONIA; PRESCRIPTION; PREVALENCE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SENTINEL SURVEILLANCE; SEROEPIDEMIOLOGY; SEROLOGY TEST KIT; SEX DIFFERENCE; UPPER RESPIRATORY TRACT INFECTION; ADOLESCENT; ADULT; AGE; AGED; CHILD; COMMUNITY-ACQUIRED INFECTIONS; FEMALE; INFANT; ISOLATION AND PURIFICATION; MALE; MIDDLE AGED; MYCOPLASMA PNEUMONIAE; NEWBORN; PNEUMONIA, MYCOPLASMA; PRESCHOOL CHILD; UNITED KINGDOM; VERY ELDERLY; YOUNG ADULT;

MYCOPLASMA PNEUMONIAE;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; COMMUNITY-ACQUIRED INFECTIONS; FEMALE; HOSPITALIZATION; HUMANS; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; MYCOPLASMA PNEUMONIAE; PNEUMONIA, MYCOPLASMA; PREVALENCE; RETROSPECTIVE STUDIES; SENTINEL SURVEILLANCE; WALES; YOUNG ADULT;

EID: 84906790512     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/1469-0691.12499     Document Type: Article

References (20)

1. Waites KB, Talkington DF. Mycoplasma pneumoniae and its role as a human pathogen. Clin Microbiol Rev 2004; 17: 697-728.
2. Park SJ, Lee YM, Lee CH, Cho JH, Lee JH. A case of splenic infarction possibly attributable to Mycoplasma pneumoniae infection without accompanying pneumonia. J Infect Chemother 2012; 18: 945-947.
3. Wang K, Gill P, Perera R, Thomson A, Mant D, Harnden A. Clinical symptoms and signs for the diagnosis of Mycoplasma pneumoniae in children and adolescents with community-acquired pneumonia. Cochrane Database Syst Rev 2012; 10: CD009175.
4. Sargenti NS, de Paulo LF, Rosa RR, Durighetto AF. Stevens-Johnson syndrome: an oral viewpoint. Int J Pediatr Otorhinolaryngol 2013; 77: 284-286.
5. Rasul S, Farhat F, Endailalu Y, Tabassum KF, Poddar V. Mycoplasma pneumoniae-Induced-Stevens Johnson syndrome: rare occurrence in an adult patient. Case Rep Med 2012; 2012: 430490.
6. Hong SJ. The role of Mycoplasma pneumoniae infection in asthma. Allergy Asthma Immunol Res 2012; 4: 59-61.
7. Uldum SA, Bangsborg JM, Gahrn-Hansen B et al. Epidemic of Mycoplasma pneumoniae infection in Denmark, 2010 and 2011. Euro Surveill 2012; 17: 27-30.
8. Blystad H, Anestad G, Vestrheim DF, Madsen S, Ronning K. Increased incidence of Mycoplasma pneumoniae infection in Norway 2011. Euro Surveill 2012; 17: 24-26.
9. Polkowska A, Harjunpaa A, Toikkanen S et al. Increased incidence of Mycoplasma pneumoniae infection in Finland, 2010-2011. Euro Surveill 2012; 17: 20-23.
10. Chalker V, Stocki T, Litt D et al. Increased detection of Mycoplasma pneumoniae infection in children in England and Wales, October 2011 to January 2012. Euro Surveill 2012; 17: 5-9.
11. Linde A, Ternhag A, Torner A, Claesson B. Antibiotic prescriptions and laboratory-confirmed cases of Mycoplasma pneumoniae during the epidemic in Sweden in 2011. Euro Surveill 2012; 17: 10-13.
12. Thacker WL, Talkington DF. Analysis of complement fixation and commercial enzyme immunoassays for detection of antibodies to Mycoplasma pneumoniae in human serum. Clin Diagn Lab Immunol 2000; 7: 778-780.
13. Waites KB, Xiao L, Paralanov V, Viscardi RM, Glass JI. Molecular methods for the detection of Mycoplasma and ureaplasma infections in humans: a paper from the 2011 William Beaumont Hospital Symposium on molecular pathology. J Mol Diagn 2012; 14: 437-450.
14. Talkington DF, Shott S, Fallon MT, Schwartz SB, Thacker WL. Analysis of eight commercial enzyme immunoassay tests for detection of antibodies to Mycoplasma pneumoniae in human serum. Clin Diagn Lab Immunol 2004; 11: 862-867.
15. Loens K, Goossens H, Ieven M. Acute respiratory infection due to Mycoplasma pneumoniae: current status of diagnostic methods. Eur J Clin Microbiol Infect Dis 2010; 29: 1055-1069.
16. Dumke R, Strubel A, Cyncynatus C et al. Optimized serodiagnosis of Mycoplasma pneumoniae infections. Diagn Microbiol Infect Dis 2012; 73: 200-203.
17. Morozumi M, Takahashi T, Ubukata K. Macrolide-resistant Mycoplasma pneumoniae: characteristics of isolates and clinical aspects of community-acquired pneumonia. J Infect Chemother 2010; 16: 78-86.
18. Gunson RN, Carman WF. During the summer 2009 outbreak of "swine flu" in Scotland what respiratory pathogens were diagnosed as H1N1/2009? BMC Infect Dis 2011; 11: 192.
19. Moore C, Gatica L, Jones T et al. Collect, boil and amplify-a simple approach for the detection of three common viruses associated with epidemic keratoconjunctivitis, conjunctivitis and dendritic ulcers. J Virol Methods 2013; 189: 238-241.
20. Moore C, Corden S, Sinha S, Jones R. Dry cotton or flocked respiratory swabs as a simple collection technique for the molecular detection of respiratory viruses using real-time NASBA. J Virol Methods 2008; 153: 84-89.